EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immunogenetic Divergence in Pediatric Type 1 Diabetes: A Sibling-Controlled Analysis

Serpil Albayrak, Murat Karaoğlan, Mehmet Keskin, Ahmet Yıldırım

European Journal of Therapeutics · 10.06.2026

DOI: 10.58600/eurjther2993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Therapeutics, online erschienen am 10.06.2026. Verfasst von Serpil Albayrak und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Type 1 Diabetes Mellitus (T1DM) is an autoimmune condition characterized by progressive pancreatic β-cell destruction, with high familial clustering rates. Siblings of index cases with T1DM represent a critical population for understanding immunogenetic mechanisms, as they share genetic backgrounds while demonstrating variable disease expression. Islet-specific autoantibodies and human leukocyte antigen (HLA) haplotypes are pivotal markers for early risk identification in at-risk siblings. This study aimed to characterize and compare immunological signatures between pediatric index cases with T1DM and their unaffected siblings, with particular emphasis on the utility of combined autoantibody and HLA profiling for predicting disease risk in the sibling population.

Methods

A retrospective cross-sectional study was conducted with 230 participants (46 index cases with T1DM and 184 unaffected siblings) recruited from a tertiary pediatric endocrinology clinic. Serum levels of anti-glutamic acid decarboxylase antibodies (anti-GAD), anti-islet cell antibodies (anti-ICA), anti-insulin autoantibodies (anti-IAA), insulin, C-peptide, and glycated hemoglobin (HbA1c) were measured. HLA-DR and -DQ loci were genotyped using high-resolution sequence-based typing.

Results

Index cases with T1DM had significantly higher positivity and titers for anti-GAD and anti-ICA (p

Zitieren

APA

Albayrak, S., Karaoğlan, M., Keskin, M., & Yıldırım, A. (2026). Immunogenetic Divergence in Pediatric Type 1 Diabetes: A Sibling-Controlled Analysis. European Journal of Therapeutics. https://doi.org/10.58600/eurjther2993

Vancouver

Albayrak S, Karaoğlan M, Keskin M, Yıldırım A. Immunogenetic Divergence in Pediatric Type 1 Diabetes: A Sibling-Controlled Analysis. European Journal of Therapeutics. 2026. doi:10.58600/eurjther2993

BibTeX
@article{Albayrak2026,
  author = {Albayrak, Serpil and Karaoğlan, Murat and Keskin, Mehmet and Yıldırım, Ahmet},
  title = {Immunogenetic Divergence in Pediatric Type 1 Diabetes: A Sibling-Controlled Analysis},
  journal = {European Journal of Therapeutics},
  year = {2026},
  doi = {10.58600/eurjther2993}
}
Kostenlos starten →